Company: PBH
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0001295947-25-000029
Chunk: 0

Company: Prestige Consumer Healthcare Inc.
Filing Date: 2025-08-07
Form: 10-Q
Item: Item 3
Chunk 0
---
ITEM 3.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Interest Rate Risk

Our 2012 ABL Revolver is variable rate debt.  At June 30, 2025, the 2012 ABL Revolver had a zero balance and therefore none of our debt carried a variable rate of interest at June 30, 2025.  

Foreign Currency Exchange Rate Risk 

During the three months ended June 30, 2025 and 2024, approximately 14.5% and 13.6%, respectively, of our gross revenues were denominated in currencies other than the U.S. Dollar.  As such, we are exposed to transactions that are sensitive to foreign currency exchange rates.  These transactions are primarily with respect to the Canadian and Australian Dollars.  

We performed a sensitivity analysis with respect to exchange rates for the three months ended June 30, 2025 and 2024.  Holding all other variables constant, and assuming a hypothetical 10.0% adverse change in foreign currency exchange rates, this analysis resulted in a less than 5.0% impact on pre-tax income of approximately $0.8 million for the three months ended June 30, 2025 and approximately $2.0 million for the three months ended June 30, 2024.